Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinomas treated by surgery

被引：28
作者：
Choi K.-H. [1 ]
Yoo I.R. [1 ]
Han E.J. [1 ]
Kim Y.S. [2 ]
Kim G.W. [2 ]
Na S.J. [1 ]
Sun D.-I. [3 ]
Jung S.L. [1 ]
Jung C.-K. [4 ]
Kim M.-S. [3 ]
Lee S.-Y. [1 ]
Kim S.H. [1 ]
机构：
[1] Department of Radiology, The Catholic University of Korea, Seoul
[2] Department of Radiation Oncology, The Catholic University of Korea, Seoul
[3] Department of Otolaryngology-Head and Neck Surgery, The Catholic University of Korea, Seoul
[4] Department of Hospital Pathology, The Catholic University of Korea, Seoul
来源：
Nuclear Medicine and Molecular Imaging | 2011年 / 45卷 / 1期
关键词：
FDG PET/CT; Head and neck squamous cell carcinoma; Metabolic tumor volume; Prognostic factor; Surgery;
D O I：
10.1007/s13139-010-0063-7
中图分类号：
学科分类号：
摘要：
Purpose: We assessed the prognostic value of metabolic tumor volume (MTV) measured using18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) inpatients with locally advanced head and neck squamous cell carcinoma (HNSCC). Methods: We retrospectively reviewed 56 patients (51 men, five women; mean age 56.0±8.8years) who had locally advanced HNSCC and underwent FDG PET/CT for initial evaluation. All patients had surgical resection and radiotherapy with or without concurrent chemotherapy. The peak standardized uptake value (SUVpeak) and MTV of the target lesion, including primary HNSCC andmetastatic cervical lymph nodes, were measured from FDG PET/CT images. We compared SUVpeak, MTV, and clinicopathologic variables such as age, Eastern Cooperative Oncology Group (ECOG) performance status, pN stage, pT stage, TNM stage, histologic grade and treatment modality to disease-free survival (DFS) and overall survival (OS). Results: On the initial FDG PET/CT scans, the median SUVpeak was 7.8 (range, 1.8-19.0) and MTV was17.0 cm3 (range, 0.1-131.0 cm3). The estimated 2-year DFS and OS rates were 67.2% and 81.8%. The cutoff points of SUVpeak 6.2 and MTV 20.7 cm3 were the best discriminative values for predicting clinical outcome. MTV and ECOG performance status were significantly related to DFS and OS on univariate and multivariate analyses (p<0.05). Conclusion The MTV obtained from initial FDG PET/CT scan is a significant prognostic factor for disease recurrence and mortality in locally advanced HNSCC treated with surgery and radiotherapy with or without chemotherapy. © Korean Society of Nuclear Medicine 2010.
引用
收藏
页码：43 / 51
页数：8
相关论文
共 39 条
  • [1] Subramaniam R.M., Truong M., Peller P., Sakai O., Mercier G., Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer, AJNR Am J Neuroradiol, (2009)
  • [2] Allal A.S., Dulguerov P., Allaoua M., Haenggeli C.A., el El-Ghazi A., Lehmann W., Et al., Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy, J Clin Oncol, 20, pp. 1398-1404, (2002)
  • [3] Minn H., Clavo A.C., Grenman R., Wahl R.L., In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous cell carcinoma of the head and neck, J Nucl Med, 36, pp. 252-258, (1995)
  • [4] Minn H., Joensuu H., Ahonen A., Klemi P., Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors, Cancer, 61, pp. 1776-1781, (1988)
  • [5] Jacob R., Welkoborsky H.J., Mann W.J., Jauch M., Amedee R., [Fluorine-18]fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous cell carcinoma of the head and neck, ORL J Otorhinolaryngol Relat Spec, 63, pp. 307-313, (2001)
  • [6] Minn H., Lapela M., Klemi P.J., Grenman R., Leskinen S., Lindholm P., Et al., Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer, J Nucl Med, 38, pp. 1907-1911, (1997)
  • [7] Allal A.S., Slosman D.O., Kebdani T., Allaoua M., Lehmann W., Dulguerov P., Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose, Int J Radiat Oncol Biol Phys, 59, pp. 1295-1300, (2004)
  • [8] Roh J.L., Pae K.H., Choi S.H., Kim J.S., Lee S., Kim S.B., Et al., 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx, Eur J Surg Oncol, 33, pp. 790-795, (2007)
  • [9] Torizuka T., Tanizaki Y., Kanno T., Futatsubashi M., Naitou K., Ueda Y., Et al., Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer, AJR Am J Roentgenol, 192, pp. 156-160, (2009)
  • [10] Mukherji S.K., Schmalfuss I.M., Castelijns J., Mancuso A.A., Clinical applications of tumor volume measurements for predicting outcome in patients with squamous cell carcinoma of the upper aerodigestive tract, AJNR Am J Neuroradiology, 25, pp. 1425-1432, (2004)
1234